Abstract
To assess cancers diagnosed and the stage of cancer at the time of diagnosis among low-income, under-insured, or uninsured women who received services through the National Breast and Cervical Cancer Early Detection Program (NBCCEDP). Using the NBCCEDP database, we examined the number and percent of women diagnosed during 2009-2011 with in situ breast cancer, invasive breast cancer, and invasive cervical cancer by demographic and clinical characteristics, including age, race and ethnicity, test indication (screening or diagnostic), symptoms (for breast cancer), and screening history (for cervical cancer). We examined these characteristics by stage at diagnosis, a new variable included in the database obtained by linking with state-based central cancer registries. There were 11,569 women diagnosed with invasive breast cancer, 1,988 with in situ breast cancer, and 583 with invasive cervical cancer through the NBCCEDP. Women who reported breast symptoms or who had diagnostic mammography were more likely to be diagnosed with breast cancer, and at a later stage, than those who did not have symptoms or who had screening mammography. Women who had been rarely or never screened for cervical cancer were more likely to be diagnosed with c...Continue Reading
References
Jun 1, 1995·American Journal of Public Health·D T JanerichA P Polednak
Apr 21, 1999·Lancet·M A RichardsA J Ramirez
May 23, 2000·Cancer·H Y SungR A Hiatt
Nov 19, 2009·Annals of Internal Medicine·Heidi D NelsonUNKNOWN U.S. Preventive Services Task Force
Nov 26, 2009·Journal of the National Comprehensive Cancer Network : JNCCN·Therese B BeversUNKNOWN National Comprehensive Cancer Network
Feb 25, 2010·Annals of Surgical Oncology·Stephen B Edge, Carolyn C Compton
May 5, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Christine M Pierce CampbellAnna R Giuliano
Jun 20, 2012·Annals of Internal Medicine·Virginia A Moyer, UNKNOWN U.S. Preventive Services Task Force
Sep 11, 2013·Cancer·Matthew L WebbBarbara L Smith
Aug 8, 2014·Cancer·Jacqueline W MillerLisa C Richardson
Aug 8, 2014·Cancer·Marcus PlesciaDjenaba Joseph
Mar 13, 2015·Cancer Causes & Control : CCC·Manxia WuA Blythe Ryerson
Mar 18, 2015·Cancer Causes & Control : CCC·David H HowardIngrid J Hall
Mar 19, 2015·Cancer Causes & Control : CCC·Florence K L TangkaIngrid J Hall
May 2, 2015·Cancer Causes & Control : CCC·David H HowardIngrid J Hall
Citations
Mar 26, 2016·Infectious Agents and Cancer·Jonah MusaAtiene S Sagay
Mar 22, 2015·Cancer Causes & Control : CCC·Gery P GuyJanet Royalty
Mar 19, 2015·Cancer Causes & Control : CCC·Mary C White, Faye L Wong
May 20, 2016·PloS One·Andrzej NowakowskiWłodzimierz Baranowski
Dec 6, 2017·Cancer·Mary C WhiteHannah K Weir
Sep 6, 2017·PloS One·Jonah MusaNeil Jordan
Jan 8, 2019·Journal of Women's Health·Kathy L MacLaughlinLila J Finney Rutten
Jan 25, 2018·BMC Cancer·Vladimir DruelMarie-Eve Rougé Bugat
Apr 14, 2019·International Journal of Cancer. Journal International Du Cancer·Angela A ClevelandUNKNOWN HPV-IMPACT Working Group
Nov 24, 2018·BMC Health Services Research·Jonah MusaMelissa A Simon
Jun 3, 2020·JCO Global Oncology·Alba J Kihn-AlarcónAngel Velarde
Jan 24, 2018·American Journal of Clinical Oncology·Bonnie Jerome-D'EmiliaKatherine Hansen
Aug 26, 2020·Cancer Causes & Control : CCC·Joëlle Atere-RobertsIngrid J Hall
Sep 22, 2017·MMWR. Morbidity and Mortality Weekly Report·Christina I FowlerNancy Mautone-Smith
Nov 16, 2019·Scientific Reports·Li NiuHutcha Sriplung
Aug 7, 2019·Journal of Clinical Medicine·Charles C N WangMing-Feng Hou
May 26, 2018·Scientific Reports·Terisse A BrocatoZhihui Wang
Dec 5, 2019·Infectious Agents and Cancer·Jonah MusaRobert L Murphy
Oct 9, 2019·Journal of Public Health Management and Practice : JPHMP·Sherri G HomanJill Lucht
Aug 12, 2021·Journal of Gynecologic Oncology·Cam Nhung BuiKui Son Choi